doi: 10.1177/2047487319878371 45
It's something like 27 more gallbladder-related events per every 10,000 patients treated per year, so it's a pretty small absolute risk. He added that the incidence of gallbladder events often increases after weight loss in general, but some studies suggest that GLP-1 drugs slow down gallbladder motility which could create a sludge that leads to gallstones (8)
Canfosfamide Canfosfamide, also known as TLK286, is a GSH analogue activated by GSTP1-1 into a GSH derivative and phosphorodiaminate, an alkylating metabolite that forms covalent linkages with DNA (Fig
Obstetrics and Gynecology Clinics of North America, 29 (11), 768780
Without addressing the hormonal trigger alongside UV, melasma treatment alone rarely produces sustained clearance
Real-world effectiveness of GLP-1 receptor agonists in clinical practice